| Literature DB >> 26695515 |
Miriam Ayuso1, Almudena Fernández2, Yolanda Núñez2, Rita Benítez2, Beatriz Isabel1, Carmen Barragán2, Ana Isabel Fernández2, Ana Isabel Rey1, Juan F Medrano3, Ángela Cánovas3, Antonio González-Bulnes4, Clemente López-Bote1, Cristina Ovilo2.
Abstract
Iberian ham production includes both purebred (IB) and Duroc-crossbred (IBxDU) Iberian pigs, which show important differences in meat quality and production traits, such as muscle growth and fatness. This experiment was conducted to investigate gene expression differences, transcriptional regulation and genetic polymorphisms that could be associated with the observed phenotypic differences between IB and IBxDU pigs. Nine IB and 10 IBxDU pigs were slaughtered at birth. Morphometric measures and blood samples were obtained and samples from Biceps femoris muscle were employed for compositional and transcriptome analysis by RNA-Seq technology. Phenotypic differences were evident at this early age, including greater body size and weight in IBxDU and greater Biceps femoris intramuscular fat and plasma cholesterol content in IB newborns. We detected 149 differentially expressed genes between IB and IBxDU neonates (p < 0.01 and Fold-Change > 1. 5). Several were related to adipose and muscle tissues development (DLK1, FGF21 or UBC). The functional interpretation of the transcriptomic differences revealed enrichment of functions and pathways related to lipid metabolism in IB and to cellular and muscle growth in IBxDU pigs. Protein catabolism, cholesterol biosynthesis and immune system were functions enriched in both genotypes. We identified transcription factors potentially affecting the observed gene expression differences. Some of them have known functions on adipogenesis (CEBPA, EGRs), lipid metabolism (PPARGC1B) and myogenesis (FOXOs, MEF2D, MYOD1), which suggest a key role in the meat quality differences existing between IB and IBxDU hams. We also identified several polymorphisms showing differential segregation between IB and IBxDU pigs. Among them, non-synonymous variants were detected in several transcription factors as PPARGC1B and TRIM63 genes, which could be associated to altered gene function. Taken together, these results provide information about candidate genes, metabolic pathways and genetic polymorphisms potentially involved in phenotypic differences between IB and IBxDU pigs associated to meat quality and production traits.Entities:
Mesh:
Substances:
Year: 2015 PMID: 26695515 PMCID: PMC4687939 DOI: 10.1371/journal.pone.0145162
Source DB: PubMed Journal: PLoS One ISSN: 1932-6203 Impact factor: 3.240
Carcass, Biceps Femoris and metabolism phenotypic characteristics in IB and IBxDU piglets.
| Genetic type | SEM |
| ||
|---|---|---|---|---|
| IBxDU | IB | |||
| Carcass characteristics | ||||
| Carcass weight, kg | 1.41 | 0.96 | 0.05 | 0.0005 |
| Ham weight, kg | 0.16 | 0.11 | 0.00 | 0.0008 |
| Total body lenght, cm | 40.20 | 35.50 | 0.31 | 0.0004 |
| Ham lenght, cm | 7.45 | 6.33 | 0.12 | 0.0009 |
| Forelimb lenght, cm | 12.35 | 10.83 | 0.12 | 0.0042 |
| Hind limb lenght, cm | 15.95 | 13.83 | 0.12 | 0.0016 |
| Torax circumference, cm | 25.15 | 22.06 | 0.14 | 0.0010 |
| Abdomen circumference, cm | 18.90 | 17.28 | 0.19 | 0.0486 |
| Ham circumference, cm | 12.55 | 10.89 | 0.15 | 0.0020 |
| Lipid and glucose metabolism-related plasma indicators | ||||
| Cholesterol, mg/dl | 62.19 | 102.36 | 5.60 | 0.0030 |
| Fructosamine, mg/dl | 169.70 | 133.67 | 10.37 | 0.1009 |
| Glucose, mg/dl | 132.40 | 123.44 | 10.80 | 0.6839 |
| LDL | 42.16 | 45.82 | 4.40 | 0.4496 |
| HDL | 22.38 | 41.20 | 4.25 | 0.0176 |
| Triglycerides, mg/dl | 30.00 | 76.67 | 5.11 | 0.0003 |
|
| ||||
| IMF | 1.72 | 2.21 | 0.09 | 0.0142 |
| C12:0 | 0.65 | 0.58 | 0.03 | 0.2321 |
| C14:0 | 2.57 | 2.32 | 0.12 | 0.3189 |
| C15:1 | 1.28 | 1.18 | 0.06 | 0.3762 |
| C16:0 | 25.90 | 25.44 | 0.19 | 0.2379 |
| C16:1 n-9 | 1.90 | 2.09 | 0.05 | 0.3854 |
| C16:1 n-7 | 5.38 | 4.57 | 0.21 | 0.0773 |
| C17:0 | 1.69 | 1.44 | 0.07 | 0.0814 |
| C17:1 | 0.91 | 0.81 | 0.06 | 0.3858 |
| C18:0 | 10.85 | 9.96 | 0.25 | 0.1014 |
| C18:1 n-9 | 23.80 | 25.82 | 0.56 | 0.0921 |
| C18:1 n-7 | 6.15 | 5.69 | 0.18 | 0.2163 |
| C18:2 n-6 | 7.31 | 9.17 | 0.60 | 0.1395 |
| C20:1 n-9 | 0.53 | 0.53 | 0.01 | 0.9701 |
| C20:2 n-6 | 0.41 | 0.40 | 0.03 | 0.8331 |
| C20:3 n-6 | 0.62 | 0.55 | 0.02 | 0.0293 |
| C20:4 n-6 | 6.31 | 5.99 | 0.20 | 0.4264 |
| C22:1 n-9 | 1.21 | 1.08 | 0.05 | 0.1956 |
| C22:4 n-6 | 1.58 | 1.27 | 0.09 | 0.0925 |
| C22:5 n-3 | 0.48 | 0.50 | 0.02 | 0.5405 |
| C22:6 n-3 | 0.67 | 0.62 | 0.02 | 0.1959 |
| ∑SFA | 41.66 | 39.74 | 0.42 | 0.0350 |
| ∑MUFA | 41.01 | 41.77 | 0.40 | 0.3530 |
| ∑PUFA | 17.34 | 18.49 | 0.50 | 0.2639 |
| UI | 96.20 | 97.79 | 0.90 | 0.3904 |
| ∑n-3 | 1.77 | 1.67 | 0.04 | 0.1940 |
| ∑n-6 | 15.56 | 16.82 | 0.48 | 0.2089 |
| ∑n-6/∑n-3 | 8.78 | 10.17 | 0.30 | 0.0319 |
| ∑MUFA/∑SFA | 0.99 | 1.05 | 0.02 | 0.0659 |
1 IBxDU = Iberian x Duroc crossbred pigs (n = 10)
2 IB = Purebred Iberian pigs (n = 9)
3SEM = Standard error of the mean
4LDL = Low density lipoproteins
5HDL = High density lipoproteins
6IMF = Intramuscular fat
7ΣSFA = Sum of saturated fatty acids
8ΣMUFA = Sum of monounsaturated fatty acids
9ΣPUFA = Sum of polyunsaturated fatty acids
10UI = Unsaturation index = 1 × (% monoenoics) +2 × (% dienoics) +3 × (% trienoics) +4 × (% tetraenoics) +5 × (% pentaenoics) +6 × (% hexaenoics) [126]
11Σn3 = Sum of n-3 fatty acids
12Σn6 = Sum of n-6 fatty acids
Gene Ontology (GO) overrepresented terms regarding the biological process category.
|
|
|
| Term name | |
|---|---|---|---|---|
| COMMON | GO:0007165 | 9.54E-07 | 6.96E-05 | Signal transduction |
| GO:0031323 | 3.81E-06 | 1.39E-04 | Regulation of cellular metabolic process | |
| GO:0009059 | 6.10E-05 | 6.37E-04 | Macromolecule biosynthetic process | |
| GO:0044267 | 1.22E-04 | 8.10E-04 | Cellular protein metabolic process | |
| GO:0010646 | 2.44E-04 | 1.11E-03 | Regulation of cell communication | |
| GO:0030154 | 2.44E-04 | 1.11E-03 | Cell differentiation | |
| GO:0048584 | 7.81E-03 | 1.84E-02 | Positive regulation of response to stimulus | |
| IB | GO:0010467 | 1.22E-04 | 8.10E-04 | Gene expression |
| GO:0043412 | 1.22E-04 | 8.10E-04 | Macromolecule modification | |
| GO:0036211 | 2.44E-04 | 1.11E-03 | Protein modification process | |
| GO:0009889 | 4.88E-04 | 1.98E-03 | Regulation of biosynthetic process | |
| GO:0090304 | 9.77E-04 | 3.56E-03 | Nucleic acid metabolic process | |
| GO:0019438 | 1.95E-03 | 5.48E-03 | Aromatic compound biosynthetic process | |
| GO:0016070 | 1.95E-03 | 5.48E-03 | RNA metabolic process | |
| GO:0023056 | 7.81E-03 | 1.84E-02 | Positive regulation of signaling | |
| IBxDU | GO:0002684 | 1.95E-03 | 1.86E-02 | Positive regulation of immune system process |
| GO:0050790 | 7.81E-03 | 3.49E-02 | Regulation of catalytic activity | |
| GO:0016337 | 7.81E-03 | 3.49E-02 | Single organismal cell-cell adhesion |
1 IB = Purebred Iberian pigs
2 IBxDU = Iberian X Duroc crossbred pigs
*GO terms are considered either common, when they are enriched in both genetic types and specific when the GO term is only enriched in one of the two genetic types.
Fig 1Enriched biological functions in Iberian (IB) pigs.
The network generated by IPA software shows enriched biological functions in IB pigs (blue color) related to lipid metabolism and muscle atrophy. Lipid synthesis is upregulated in IB pigs. Muscle and protein degradation are also enriched, probably leading to a decreased muscle growth in those pigs. The network includes several transcription factors which may play key roles in the functional differences between genetic types, in agreement with the regulators study (FOXO3, ATF3, TRIM63).
Fig 3Enriched biological functions potentially related to muscle growth in crossbred (IBxDU) pigs.
The network generated by IPA software shows enriched biological functions in IBxDU pigs (orange color) potentially related to muscle growth and body size, functions regulated by a wide variety of genes, from growth factors (FGF21) to immune system related genes (MARCO, MSR1).
Pathways significantly enriched in Purebred (IB) and Duroc-crossbred (IBxDU) Iberian pigs.
| IB | IBxDU | ||
|---|---|---|---|
| Pathway |
| Pathway |
|
| PI3K Signaling in B Lymphocytes | <0.001 | Agranulocyte Adhesion and Diapedesis | <0.001 |
| NRF2-mediated Oxidative Stress Response | 0.0022 | LXR/RXR Activation | <0.001 |
| Glutamine Biosynthesis I | 0.0031 | Atherosclerosis Signaling | <0.001 |
| IL-17A Signaling in Fibroblasts | 0.0051 | Aldosterone Signaling in Epithelial Cells | 0.0012 |
| April Mediated Signaling | 0.0060 | Granulocyte Adhesion and Diapedesis | 0.0019 |
| LXR/RXR Activation | 0.0060 | TREM1 Signaling | 0.0050 |
| Epoxysqualene Biosynthesis | 0.0062 | Protein Ubiquitination Pathway | 0.0054 |
| B Cell Activating Factor Signaling | 0.0066 | Citrulline-Nitric Oxide Cycle | 0.0071 |
| Thyronamine and Iodothyronamine Metabolism | 0.0091 | IL-12 Signaling and Production in Macrophages | 0.0155 |
| Thyroid Hormone Metabolism I (via Deiodination) | 0.0091 | Superpathway of Citrulline Metabolism | 0.0195 |
| Wnt/Ca+ pathway | 0.0129 | nNOS Signaling in Skeletal Muscle Cells | 0.0209 |
| Tight Junction Signaling | 0.0145 | Differential Regulation of Cytokine Production in Macrophages and T Helper Cells by IL-17A and IL-17F | 0.0251 |
| AcutePhase Response Signaling | 0.0151 | Production of Nitric Oxide and Reactive Oxygen Species in Macrophages | 0.0263 |
| ERK5 Signaling | 0.0158 | Clathrin-mediated Endocytosis Signaling | 0.0275 |
| Growth Hormone Signaling | 0.0191 | Actin Cytoskeleton Signaling | 0.0372 |
| Clathrin-mediated Endocytosis Signaling | 0.0191 | Role of p14/p19ARF in Tumor Suppression | 0.0417 |
| Melatonin Signaling | 0.0195 | IL-17A Signaling in Fibroblasts | 0.0468 |
| Toll-like Receptor Signaling | 0.0214 | ||
| Regulation of IL-2 Expression in Activated and Anergic T Lymphocytes | 0.0245 | ||
| UVA-Induced MAPK Signaling | 0.0295 | ||
| Antioxidant Action of Vitamin C | 0.0355 | ||
| IGF-1 Signaling | 0.0355 | ||
| T Cell Receptor Signaling | 0.0355 | ||
| Role of IL-17A in Psoriasis | 0.0389 | ||
| Cholesterol Biosynthesis I | 0.0389 | ||
| Cholesterol Biosynthesis II (24. 25-dihydrolanosterol) | 0.0389 | ||
| Cholesterol Biosynthesis III (via Desmosterol) | 0.0389 | ||
| Vitamin-C Transport | 0.0417 | ||
| Glucocorticoid Receptor Signaling | 0.0457 | ||
| FattyAcid α-oxidation | 0.0479 | ||
1 IB = Purebred Iberian pigs
2 IBxDU = Iberian X Duroc crossbred pigs
Fig 4Gene network containing DE genes related to Cellular Compromise, Organismal Injury and Abnormalities and Skeletal and Muscular Disorders.
This gene network shows several genes functionally interconnected and closely associated with the ubiquitin C (UBC), a central molecule in the network responsible for protein degradation. These genes are differentially expressed between genotypes and indicate the importance of the ubiquitination process in muscle growth of newborn pigs.
Fig 2Enriched biological functions related to cell growth in crossbred (IBxDU) pigs.
The network generated by IPA software shows enriched biological functions in IBxDU pigs (orange color) involved in cellular growth and differentiation. Upregulation of several chemokines as well as a myosin in IBxDU pigs, and downregulation of some transcription factors (FOXO3, ATF3) are responsible for the enrichment of such functions in crossbreds.
Fig 5Gene network containing genes upregulated in Iberian (IB) pigs related to Amino Acid Metabolism, Molecular Transport and Small Molecule Biochemistry.
The gene network shows interactions between cholesterol and lipid metabolism-related genes (LDL, APOM, FDFT1, SLC2A4, etc.) upregulated in Iberian pigs.
Potential regulators affecting gene expression that are: a) differentially expressed (DE) between IB and IBxDU; b) identified by Ingenuity Pathways Analysis (IPA) software or c) identified by RIFs study.
| Ensembl ID | GENE | DE regulators | IPA—Regulators | RIFs study | |||
|
| FC Change | Z-score |
| RIF1(z) | RIF2(z) | ||
| ENSSSCG00000006036 |
| 2.27E-06 | -4.37 | ||||
| ENSSSCG00000008123 |
| 2.01 | |||||
| ENSSSCG00000015972 |
| 4.40E-02 | |||||
| ENSSSCG00000015595 |
| 2.48E-04 | -7.76 | ||||
| ENSSSCG00000000084 |
| 1.42E-02 | |||||
| ENSSSCG00000012241 |
| 4.17E-03 | |||||
| ENSSSCG00000013397 |
| -2.22 | |||||
| ENSSSCG00000008377 |
| -2.11 | |||||
| ENSSSCG00000002866 |
| -2.426 | 7.32E-03 | ||||
| ENSSSCG00000002867 |
| 3.60 | |||||
| ENSSSCG00000006752 |
| 2.45 | |||||
| ENSSSCG00000011274 |
| -2.183 | 1.01E-02 | ||||
| ENSSSCG00000014336 |
| -0.254 | 5.28E-03 | ||||
| ENSSSCG00000010224 |
| 2.01E-02 | 2.21 | ||||
| ENSSSCG00000008443 |
| 4.01E-02 | |||||
| ENSSSCG00000002383 |
| 1.38E-03 | -4.39 | 0.381 | 6.14E-03 | ||
| ENSSSCG00000012967 |
| 2.76E-02 | |||||
| ENSSSCG00000007576 |
| 2.35 | |||||
| ENSSSCG00000009370 |
| 1.03E-02 | 3.22 | ||||
| ENSSSCG00000004387 |
| 7.04E-04 | -2.72 | -2.364 | 5.05E-06 | ||
| ENSSSCG00000001619 |
| 2.79 | |||||
| ENSSSCG00000015733 |
| 2.60 | |||||
| ENSSSCG00000007720 |
| 1.66E-02 | |||||
| ENSSSCG00000000846 |
| 2.34 | |||||
| ENSSSCG00000014388 |
| 2.36E-02 | |||||
| ENSSSCG00000010472 |
| 4.89E-02 | |||||
| ENSSSCG00000004138 |
| 1.70E-04 | |||||
| ENSSSCG00000009327 |
| 3.67E-03 | |||||
| ENSSSCG00000009704 |
| 2.55 | |||||
| ENSSSCG00000008898 |
| 1.66E-02 | |||||
| ENSSSCG00000015985 |
| 3.59 | |||||
| ENSSSCG00000005917 |
| 9.28E-05 | |||||
| ENSSSCG00000004238 |
| 6.06E-03 | |||||
| ENSSSCG00000014277 |
| 2.49E-02 | 2.19 | ||||
| ENSSSCG00000003178 |
| 3.13E-02 | |||||
| ENSSSCG00000012853 |
| 3.08E-02 | |||||
| ENSSSCG00000008119 |
| 2.34 | |||||
| ENSSSCG00000010928 |
| -2.10 | |||||
| ENSSSCG00000006928 |
| 2.64 | |||||
| ENSSSCG00000004528 |
| 2.44E-02 | |||||
| ENSSSCG00000000552 |
| 2.35 | |||||
| ENSSSCG00000005720 |
| 2.18 | |||||
| ENSSSCG00000006482 |
| 6.93E-03 | |||||
| ENSSSCG00000012534 |
| -2.11 | |||||
| ENSSSCG00000013507 |
| 2.18 | |||||
| ENSSSCG00000012114 |
| 2.34 | |||||
| ENSSSCG00000017882 |
| 2.07E-02 | |||||
| ENSSSCG00000013375 |
| 7.26E-03 | |||||
| ENSSSCG00000015475 |
| 8.17E-06 | |||||
| ENSSSCG00000010399 |
| 3.59 | |||||
| ENSSSCG00000015987 |
| -2.206 | 2.44E-02 | ||||
| Ensembl ID | GEN | DE regulators | IPA—Regulators | RIFs study | |||
|
| FC | Z-score |
| RIF1(z) | RIF2(z) | ||
| ENSSSCG00000001952 |
| -1.279 | 3.40E-02 | ||||
| ENSSSCG00000001703 |
| 4.09E-02 | |||||
| ENSSSCG00000005385 |
| 8.17E-04 | -6.56 | ||||
| ENSSSCG00000009856 |
| 9.85E-03 | 2.29 | 3.78E-05 | |||
| ENSSSCG00000006689 |
| 3.69E-02 | |||||
| ENSSSCG00000014437 |
| 1.65E-02 | |||||
| ENSSSCG00000009746 |
| -2.25 | |||||
| ENSSSCG00000009401 |
| 1.172 | 2.29E-02 | ||||
| ENSSSCG00000008388 |
| 2.04E-03 | |||||
| ENSSSCG00000012981 |
| 0.749 | 6.16E-04 | ||||
| ENSSSCG00000017071 |
| -2.28 | |||||
| ENSSSCG00000011201 |
| -2.32 | |||||
| ENSSSCG00000001880 |
| -2.12 | |||||
| ENSSSCG00000004952 |
| 2.43 | |||||
| ENSSSCG00000004524 |
| 4.94E-02 | |||||
| ENSSSCG00000005232 |
| -2.47 | |||||
| ENSSSCG00000013629 |
| 4.00E-02 | |||||
| ENSSSCG00000006256 |
| 3.29E-02 | |||||
| ENSSSCG00000017403 |
| 3.52E-02 | |||||
| ENSSSCG00000017406 |
| 2.22 | |||||
| ENSSSCG00000010638 |
| 2.68E-02 | |||||
| ENSSSCG00000001092 |
| 2.44 | |||||
| ENSSSCG00000001544 |
| -2.06 | |||||
| ENSSSCG00000017950 |
| -1.444 | 1.21E-04 | 3.48 | 1.69 | ||
| ENSSSCG00000007208 |
| 2.84 | |||||
| ENSSSCG00000027684 |
| 7.02E-04 | -2.46 | 1.25E-02 | |||
| ENSSSCG00000015370 |
| 3.28E-03 | |||||
| ENSSSCG00000006790 |
| -2.18 | |||||
| ENSSSCG00000011953 |
| 2.10 | |||||
| ENSSSCG00000007958 |
| 2.31 | |||||
| ENSSSCG00000003233 |
| 2.86 | |||||
| ENSSSCG00000002838 |
| 2.26 | |||||
| ENSSSCG00000003070 |
| 2.24 | |||||
| ENSSSCG00000007767 |
| 2.26 | |||||
| ENSSSCG00000001206 |
| -2.84 | |||||
| ENSSSCG00000002877 |
| 2.50 | |||||
| ENSSSCG00000003244 | 2.05 | ||||||
| ENSSSCG00000011620 | -2.41 | ||||||
| ENSSSCG00000011943 | -2.07 | ||||||
| ENSSSCG00000013384 | 1.96 | ||||||
| ENSSSCG00000016700 | 3.43 | ||||||
FC: Fold-Change
Z-score: reflects the activation state of predicted transcriptional regulators. It is based on the experimentally observed gene expression, and on literature‐derived regulation direction information, which can be either “activating” or “inhibiting”
RIF1 (z) extreme scores identify those transcription factors that are consistently most differentially co-expressed with highly abundant and highly DE genes. Bootstrap 95% and 99% confidence intervals for RIF1 z-scores: -1.996/2.074 and -2.883/2.918, respectively.
RIF2 (z) extreme scores identify transcription factors with the most altered ability to predict the abundance of DE genes. Bootstrap 95% and 99% confidence intervals for RIF2 z-scores: -2.036/1.953 and -2.609/2.490, respectively
Fig 6Adipogenesis pathway.
Several transcription factors identified in the regulators study and two genes upregulated in Iberian pigs (PREF1 and GLUT4) are involved in the adipogenesis pathway. Most of them are involved in PPARG expression or activation.
Number of sequence variants present in IB and IBxDU pigs RNA-Seq data and its distribution according to localization, frequency and polymorphism type.
| IB | IBxDU | |
|---|---|---|
| Total number of variants (after filtering) | 120,998 | 125,382 |
| Variant localization | ||
| UTR Region | 20,683 | 21,808 |
| Coding region | 100,315 | 103,574 |
| Potentially fixed and segregating variants | ||
| Fixed (γ≥90%) | 46336 | 40454 |
| Segregate (γ<90%) | 74662 | 84928 |
| AA change | 18092 | 18556 |
| Variant type | ||
| SNV | 88,415 | 92,416 |
| MNV | 11,842 | 11,873 |
| Insertion | 7,863 | 7,987 |
| Deletion | 9,539 | 9,699 |
| Replacement | 3,339 | 3,407 |
IB: Iberian purebred piglets
IBxDU: Duroc crossbred Iberian piglets
Filtering: Variants with coverage < 30 or frequency < 5% were dismissed
UTR Region: Untranslated region
AA change: Variants causing a aminoacid change in the protein
SNV: Single nucleotide variant
MNV: Multiple nucleotide variant
Replacement: Neighboring SNVs and insertions or deletions.